Senior Clinical Lecturer
Sacha Howell carries out trials of new breast cancer drugs. He is particularly interested in approaches to overcome resistance to hormone therapy.
Dr Howell graduated from The University of Nottingham Medical School in 1993. After completion of basic medical training and year working overseas in Grenada he entered entered specialist training in Medical Oncology in 1999 at The Christie Hospital. He was awarded CCT in 2006, and in the same year was awarded his PhD from The University of Manchester during which he defined a previously unidentified role for prolactin signalling in breast cancer stem/progenitor cell regulation. Following a period as a senior clinical research fellow he was appointed as a Senior Lecturer at The University of Manchester in 2010. His professional time is divided between the clinical care of cancer patients at The Christie and both basic and clinical research at the CRUK Manchester Institute and The Christie respectively.